IceCure Medical Ltd. (ICCM) 近日宣布,已与一家专注于医疗健康领域的机构投资者达成协议,完成了一轮总额550万美元的私募股权融资。此次定向增发的发行价格设定在高于当前市场交易价格的水平。
这笔资金的注入将为公司推进其核心冷冻治疗技术的临床开发与商业化战略提供关键支持。通过引入单一的专业机构投资者,IceCure旨在强化其资产负债表,并加速其在微创肿瘤治疗领域的市场拓展步伐。
IceCure Medical Ltd. (ICCM) 近日宣布,已与一家专注于医疗健康领域的机构投资者达成协议,完成了一轮总额550万美元的私募股权融资。此次定向增发的发行价格设定在高于当前市场交易价格的水平。
这笔资金的注入将为公司推进其核心冷冻治疗技术的临床开发与商业化战略提供关键支持。通过引入单一的专业机构投资者,IceCure旨在强化其资产负债表,并加速其在微创肿瘤治疗领域的市场拓展步伐。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.